Market Cap (In NZD)
288.38 Million
Revenue (In NZD)
195.41 Million
Net Income (In NZD)
15.6 Million
Avg. Volume
22.07 Thousand
- Currency
- NZD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.37-3.85
- PE
- 25.0
- EPS
- 0.11
- Beta Value
- 0.373
- ISIN
- NZAFTE0001S4
- CUSIP
- -
- CIK
- -
- Shares
- 104866000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Hartley Atkinson Ph.D.
- Employee Count
- -
- Website
- https://www.aftpharm.com
- Ipo Date
- 2015-12-21
- Details
- AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
More Stocks
-
IOSIONOS Group SE
IOS
-
688363
-
SICALLOGSical Logistics Limited
SICALLOG
-
TASTTasty plc
TAST
-
INO-UN
-
002021
-
1732
-
PANXFPlatinex Inc.
PANXF